1. Martínez-Fernández, Carmen, Jha, Sweta, Aliagas, Elisabet, Nadal, Ernest, Cerón, Julián. 2023. BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13. In Cells, 12, . doi:10.3390/cells12060929. https://pubmed.ncbi.nlm.nih.gov/36980270/
2. He, Sisi, Cao, Rong, Mao, Yan, Ma, Hu, Tian, Kunming. 2023. Alternative splicing of PSMD13 mediated by genetic variants is significantly associated with endometrial cancer risk. In Journal of gynecologic oncology, 34, e40. doi:10.3802/jgo.2023.34.e40. https://pubmed.ncbi.nlm.nih.gov/36731897/
3. Li, Yun, Liu, Honghui, Liu, Na, Chen, Lin, Liu, Ruijie. 2024. Comprehensive analysis reveals the prognostic and immunological role of PSMD13 in hepatocellular carcinoma. In Mammalian genome : official journal of the International Mammalian Genome Society, 36, 317-330. doi:10.1007/s00335-024-10097-6. https://pubmed.ncbi.nlm.nih.gov/39738579/
4. Bellizzi, D, Dato, S, Cavalcante, P, Rose, G, De Benedictis, G. 2006. Characterization of a bidirectional promoter shared between two human genes related to aging: SIRT3 and PSMD13. In Genomics, 89, 143-50. doi:. https://pubmed.ncbi.nlm.nih.gov/17059877/
5. Bi, Wei, Zhu, Lihong, Zeng, Zhifen, Xu, Anding, Tao, Enxiang. 2014. Investigations into the role of 26S proteasome non-ATPase regulatory subunit 13 in neuroinflammation. In Neuroimmunomodulation, 21, 331-7. doi:10.1159/000357811. https://pubmed.ncbi.nlm.nih.gov/24642793/